CDKN2A and Hyperglycemia: For example, some studies showed that p16INK4 expression increased in diabetic TECs, whereas other studies have reported that overexpression of p21Cip1 but not other CDK inhibitors, such as p16INK4 and p27Kip1, is increased due to hyperglycemia [59].